Centro Hospitalar Universitário Lisboa Norte
Lisbon, Portugal
Location status: Recruiting
NCT Number: NCT04878224
The junctional zone (JZ) is an internal layer of the myometrium, with unique characteristics that allow its visualization as a hypoechogenic structure in three-dimensional (3D) ultrasound.
Although traditionally evaluated by magnetic resonance imaging, 3D reconstruction offers an opportunity for reliable and easily accessible assessment. The only study that evaluated the thickness of the JZ in 3D ultrasound in the context of assisted reproductive technology (ART) found that the smaller the thickness of the JZ, the greater the rate of embryonic implantation.
This project aims to evaluate the relationship between the characteristics of the ZJ in 3D ultrasound, and the clinical outcomes of ART treatments, namely in vitro fertilization cycles, intracytoplasmic sperm injection and frozen embryo transfer (FET). Additionally, the intra and inter-observer variability of the characteristics of the JZ will be determined.
In a prospective and observational study with the inclusion of 200 cases, a 3D ultrasound will be performed on the day on which the final oocyte maturation is triggered or, on FET, on the day prior to the administration of progesterone.
The images will be evaluated independently by two observers. The principal investigator will evaluate the images in two stages.
After the quality of visualization of the JZ is classified, its thickness will be measured and described as regular, irregular or interrupted.
The volume of the ZJ will be obtained by subtracting the endometrial volume from the volume of the junctional zone and the endometrium.
These characteristics will be related to the clinical outcomes of each cycle: clinical pregnancy rate and abortion rate.
Interested in participating?
Request Info18 year–42 year
Female
Observational
Lisbon, Portugal
Location status: Recruiting
After explaining the study and obtaining written consent, a 3D ultrasound will be performed for uterine evaluation, on the day of the final oocyte maturation trigger in cases of IVF / ICSI. In cases of FET, the ultrasound evaluation will be carried out on the day before the start of the luteal phase support.
All ultrasounds will be performed in a standardized manner by the same operator. With an empty bladder, in a lithotomy position, a 2D transvaginal ultrasound will be performed using a GE Voluson 730 Expert® ultrasound, with an endovaginal probe with a 4-8MHz frequency. Identification of endometriosis lesions or acquired uterine abnormalities such as leiomyomas or adenomyosis will be exclusion criteria. After evaluating the number and maximum dimension of the ovarian follicles and the endometrial thickness, the three-dimensional volume box will be placed to encompass the entire uterus in longitudinal section, with minimal inclusion of para-uterine structures. A maximum acquisition angle of 90º and maximum quality will be used. To minimize artifacts, during the acquisition both the probe and the woman must remain immobile, being asked to hold their breath. Then, a three-dimensional volume will be generated by automatic 360º rotation of the transducer. For each case, two volumes will always be obtained.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 weeks
Clinical pregnancy rate
Time frame: 7 weeks
Abortion rate
Time frame: 2 years
intra-observer variability
Time frame: 2 years
inter-observer variability
Contact information is provided by the study sponsor or research team.
Isabel Barros Pereira, M.D.
CONTACT
Isabel Barros Pereira, M.D.
CONTACT
Centro Hospitalar Lisboa Norte
Other
Junctional Zone Evaluation by 3D Ultrasound and Its Relation to Clinical Outcomes in Assisted Reproductive Technology
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06686537
Body Weight, Female Urogenital Diseases
Aurora, Colorado, United States
View Trial DetailsNCT05181748
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Athens, Attica, Greece
View Trial DetailsNCT05969574
Abortion, Habitual, Abortion, Spontaneous
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
View Trial DetailsNCT04166825
Cardiovascular Diseases, Embolism and Thrombosis
Krakow, Małopolska, Poland
View Trial Details